Clinical trial
L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors
NCT00003430 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003430 |
|---|---|
| Title | L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors |
| Official title | A Pharmacokinetic Study Evaluating the Safety, Tolerability and Maximally Tolerated Dose of 7-Day Continuous Infusions of L-778,123 in Patients With Recurrent of Refractory Solid Malignancies |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | L-778, 123 |
| Enrollment | 40 |
| Start date | Apr 1, 1998 |
| Primary completion | Apr 1, 2000 |
| Completion | Apr 1, 2000 |
| First posted | Sep 13, 2004 |
| Last update posted | Jun 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: